	Antibody therapeutics product data - The Antibody Society																				
Accession	International Non-Proprietary Name	Brand Name	Target	Format	Specificity	Sequence source	Backbone	Light Chain	Conjugated / uncognugated	Linker	Payload	Payload Mechanism of Action	Fc Modifications	Reason for Fc Modifications	Therapeutic Area	Indication First Approved or Reviewed	First EU approval year	First US approval year	"First global approval (country, year)"	Expression system	 
P07766	Muromonab-CD3	Orthoclone Okt3	CD3	Full-length antibody	Monospecific	Murine	mIgG2a	kappa	Unconjugated				None	-	Immunology	Reversal of kidney transplant rejection	1986*	1986#	"US, 1986"	Murine hybridoma	
P20701	Efalizumab	Raptiva	CD11a	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				None	-	Immunology	Psoriasis	2004#	2003#	"US, 2003"	Chinese hamster ovary (CHO) cells	
P11836	Tositumomab-I131	Bexxar	CD20	Full-length antibody	Monospecific	Murine	mIgG2a	lambda	Radio-immunotherapeutic		Iodine-131	I-131 produces beta and gamma emissions	None	-	Oncology	Non-Hodgkin Lymphoma	NA	2003#	"US, 2003"	Murine hybridoma	
x	Nebacumab	Centoxin	Endotoxin	Full-length antibody	Monospecific	Human	hIgM	kappa	Unconjugated				None	-	Infectious Diseases	Gram-negative sepsis	1991*#	NA	"Netherlands, England, France, Germany, 1991"	Heteromyeloma cell line A6(H4C5)	
P16422	Edrecolomab	Panorex	EpCAM	Full-length antibody	Monospecific	Murine	mIgG2a	kappa	Unconjugated				None	-	Oncology	Colon cancer	1995*#	NA	"Germany, 1995"		
P16422	Catumaxomab	Removab	"EPCAM, CD3"	Full-length antibody	Bispecific	Hybrid Rat/Mouse	mIgG2a/k and rIgG2b/_ Hybrid	kappa/lambda	Unconjugated				None	-	Oncology	Malignant ascites	2009#	NA	"EU, 2009"	Rat-mouse hybrid-hybridoma cell line	
P01589	Daclizumab	Zinbryta; Zenapax	CD25	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				None	-	Immunology	Multiple sclerosis#; prevention of kidney transplant rejection#	2016#; 1999#	2016#; 1997#	"US, 1997"	Murine myeloma non-secreting 0 (NS0) cells	
"P08514, P05106"	Abciximab	Reopro	GPIIb/IIIa	Fab	Monospecific	Chimeric mouse/human	hIgG1 Fab	kappa	Unconjugated				Not applicable	-	Hematological Disorders	Prevention of blood clots in angioplasty	1995*	1994	"US, 1994"	Murine myeloma cells (Sp2/0)	
P11836	Rituximab	"MabThera, Rituxan"	CD20	Full-length antibody	Monospecific	Chimeric mouse/human	hIgG1	kappa	Unconjugated				None	-	Oncology	Non-Hodgkin lymphoma	1998	1997	"US, 1997"	Chinese hamster ovary (CHO) cells	
P01589	Basiliximab	Simulect	IL-2R	Full-length antibody	Monospecific	Chimeric mouse/human	hIgG1	kappa	Unconjugated				None	-	Immunology	Prevention of kidney transplant rejection	1998	1998	"US, 1998"	Murine myeloma non-secreting 0 (NS0) cells	
P03420	Palivizumab	Synagis	RSV	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				None	-	Infectious Diseases	Prevention of respiratory syncytial virus infection	1999	1998	"US, 1998"	Murine myeloma non-secreting 0 (NS0) cells	
P01375	Infliximab	Remicade	TNF	Full-length antibody	Monospecific	Chimeric mouse/human	hIgG1	kappa	Unconjugated				None	-	Immunology	Crohn disease	1999	1998	"US, 1998"	Murine myeloma cells (Sp2/0)	
P04626	Trastuzumab	Herceptin	HER2	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				None	-	Oncology	Breast cancer	2000	1998	"US, 1998"	Chinese hamster ovary (CHO) cells	
P01375	Adalimumab	Humira	TNF	Full-length antibody	Monospecific	Human	hIgG1	kappa	Unconjugated				None	-	Immunology	Rheumatoid arthritis	2003	2002	"US, 2002"	Chinese hamster ovary (CHO) cells	
P11836	Ibritumomab tiuxetan	Zevalin	CD20	Full-length antibody	Monospecific	Murine	mIgG1	kappa	Radio-immunotherapeutic	chalating agent MX-DTPA	Yttrium-90	Y-90 produces beta emissions	None	-	Oncology	Non-Hodgkin lymphoma	2004	2002	"US, 2002"	Chinese hamster ovary (CHO) cells	
P0DOX4	Omalizumab	Xolair	IgE	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				None	-	Immunology	Asthma	2005	2003	"US, 2003"	Chinese hamster ovary (CHO) cells	
P00533	Cetuximab	Erbitux	EGFR	Full-length antibody	Monospecific	Chimeric mouse/human	hIgG1	kappa	Unconjugated				None	-	Oncology	Colorectal cancer	2004	2004	"Switzerland, 2003"	Murine myeloma cells (Sp2/0)	
P15692	Bevacizumab	Avastin	VEGF	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				None	-	Oncology	Colorectal cancer	2005	2004	"US, 2004"	Chinese hamster ovary (CHO) cells	
P13612	Natalizumab	Tysabri	a4 integrin	Full-length antibody	Monospecific	Humanized	hIgG4	kappa	Unconjugated				None	-	Immunology	Multiple sclerosis	2006	2004	"US, 2004"	Murine myeloma non-secreting 0 (NS0) cells	
P00533	Panitumumab	Vectibix	EGFR	Full-length antibody	Monospecific	Human	hIgG2	kappa	Unconjugated				None	-	Oncology	Colorectal cancer	2007	2006	"US, 2006"	Chinese hamster ovary (CHO) cells	
P15692	Ranibizumab	Lucentis	VEGF	Fab	Monospecific	Humanized	hIgG1 Fab	kappa	Unconjugated				Not applicable	-	Ophthalmology	Macular degeneration	2007	2006	"US, 2006"	E. coli bacteria	
P01031	Eculizumab	Soliris	C5	Full-length antibody	Monospecific	Humanized	hIgG2(CH1-hinge)/hIgG4(CH2-CH3)	kappa	Unconjugated				None	-	Hematological Disorders	Paroxysmal nocturnal hemoglobinuria	2007	2007	"US, 2007"	Murine myeloma non-secreting 0 (NS0) cells	
P01375	Certolizumab pegol	Cimzia	TNF	PEGylated Fab	Monospecific	Humanized	hFab		PEGylated		PEG	extend half life	Not applicable	-	Immunology	Crohn disease	2009	2008	"US, 2008"	E. coli bacteria	
"Q9NPF7, P29460"	Ustekinumab	Stelara	IL-12/23	Full-length antibody	Monospecific	Human	hIgG1	kappa	Unconjugated				None	-	Immunology	Psoriasis	2009	2009	"EU, 2009"	Murine myeloma cells (Sp2/0)	
P01584	Canakinumab	Ilaris	IL-1_	Full-length antibody	Monospecific	Human	hIgG1	kappa	Unconjugated				None	-	Genetic Diseases	Muckle-Wells syndrome	2009	2009	"US, 2009"	Murine myeloma cells (Sp2/0)	
P01375	Golimumab	Simponi	TNF	Full-length antibody	Monospecific	Human	hIgG1	kappa	Unconjugated				None	-	Immunology	"Rheumatoid and psoriatic arthritis, ankylosing spondylitis"	2009	2009	"US, 2009"	Murine myeloma cells (Sp2/0)	
P11836	Ofatumumab	Arzerra	CD20	Full-length antibody	Monospecific	Human	hIgG1	kappa	Unconjugated				None	-	Oncology	Chronic lymphocytic leukemia	2010#	2009	"US, 2009"	Murine myeloma non-secreting 0 (NS0) cells	
P08887	Tocilizumab	"RoActemra, Actemra"	IL-6R	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				None	-	Immunology	Rheumatoid arthritis	2009	2010	"Japan, 2005"	Chinese hamster ovary (CHO) cells	
O14788	Denosumab	Prolia	RANK-L	Full-length antibody	Monospecific	Human	hIgG2	kappa	Unconjugated				None	-	Musculoskeletal Disorders	Bone Loss	2010	2010	"EU, 2010"	Chinese hamster ovary (CHO) cells	
Q9Y275	Belimumab	Benlysta	BLyS	Full-length antibody	Monospecific	Human	hIgG1	lambda	Unconjugated				None	-	Immunology	Systemic lupus erythematosus	2011	2011	"US, 2011"	Murine myeloma non-secreting 0 (NS0) cells	
P16410	Ipilimumab	Yervoy	CTLA-4	Full-length antibody	Monospecific	Human	hIgG1	kappa	Unconjugated				None	-	Oncology	Metastatic melanoma	2011	2011	"US, 2011"	Chinese hamster ovary (CHO) cells	
P28908	Brentuximab vedotin	Adcetris	CD30	Full-length antibody	Monospecific	Chimeric mouse/human	hIgG1	kappa	ADC	protease cleavable linker (Cathepsin cleavable valine-citrulline)	Monometyl auristan E (MMAE)	tubulin polymerization inhibitor	None	-	Oncology	"Hodgkin lymphoma, systemic anaplastic large cell lymphoma"	2012	2011	"US, 2011"	Chinese hamster ovary (CHO) cells	
P04626	Pertuzumab	Perjeta	HER2	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				None	-	Oncology	Breast Cancer	2013	2012	"US, 2012"	Chinese hamster ovary (CHO) cells	
P04626	Ado-trastuzumab emtansine	Kadcyla	HER2	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	ADC	Non-cleavable  SMCC thioether linker	DM1	tubulin polymerization inhibitor	None	-	Oncology	Breast cancer	2013	2012	"US, 2012"	Chinese hamster ovary (CHO) cells	
P13423	Raxibacumab	(Pending)	B. anthrasis PA	Full-length antibody	Monospecific	Human	hIgG1	lambda	Unconjugated				None	-	Infectious Diseases	Anthrax infection	NA	2012	"US, 2012"	Murine myeloma non-secreting 0 (NS0) cells	
P11836	Obinutuzumab	"Gazyva, Gazyvaro"	CD20	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				Low-fucose	Improve Fc_RIIIa binding/Improve ADCC	Oncology	Chronic lymphocytic leukemia	2014	2013	"US, 2013"	"Chinese hamster ovary (CHO) cells, Coexpression with GnT III and _-ManII in CHO cells (GlycoMAb Technology)"	
x	Racotumomab	Vaxira®	GM3	Full-length antibody	Monospecific	Murine	IgG1	kappa					-	-	Oncology	Non-small cell lung cancer	NA	NA	"Cuba, 2013"		
P05231	Siltuximab	Sylvant	IL-6	Full-length antibody	Monospecific	Chimeric mouse/human	hIgG1	kappa	Unconjugated				None	-	Immunology	Castleman disease	2014	2014	"US, 2014"	Chinese hamster ovary (CHO) cells	
P35968	Ramucirumab	Cyramza	VEGFR2	Full-length antibody	Monospecific	Human	hIgG1	kappa	Unconjugated				None	-	Oncology	Gastric cancer	2014	2014	"US, 2014"	Murine myeloma non-secreting 0 (NS0) cells	
P26010	Vedolizumab	Entyvio	_4_7 integrin	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				"L235A, G237"	Remove Fc effector functions	Immunology	"Ulcerative colitis, Crohn disease"	2014	2014	"US, 2014"	Chinese hamster ovary (CHO) cells	
Q15116	Nivolumab	Opdivo	PD1	Full-length antibody	Monospecific	Human	hIgG4	kappa	Unconjugated				S228P	Hinge stabilising	Oncology	"Melanoma, non-small cell lung cancer"	2015	2014	"US, 2014"	Chinese hamster ovary (CHO) cells	
Q15116	Pembrolizumab	Keytruda	PD1	Full-length antibody	Monospecific	Humanized	hIgG4	kappa	Unconjugated				S228P	Hinge stabilising	Oncology	Melanoma	2015	2014	"US, 2014"	Chinese hamster ovary (CHO) cells	
"P15391, P07766"	Blinatumomab	Blincyto	"CD19, CD3"	Tandem scFv	Bispecific	Murine	Tandem scFv	NA	Unconjugated				Not applicable	-	Oncology	Acute lymphoblastic leukemia	2015	2014	"US, 2014"	Chinese hamster ovary (CHO) cells	
P31358	Alemtuzumab	"Lemtrada; MabCampath, Campath-1H"	CD52	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				None	-	Oncology	Multiple sclerosis; chronic myeloid leukemia#	2013; 2001#	2014; 2001#	"US, 2001"	Chinese hamster ovary (CHO) cells	
Q8NBP7	Evolocumab	Repatha	PCSK9	Full-length antibody	Monospecific	Human	hIgG2	lambda	Unconjugated				None	-	Other	High cholesterol	2015	2015	"EU, 2015"	Chinese hamster ovary (CHO) cells	
	Idarucizumab	Praxbind	Dabigatran	Fab	Monospecific	Humanized	hIgG1 Fab	kappa	Unconjugated				Not applicable	-	Hematological Disorders	Reversal of dabigatran-induced anticoagulation	2015	2015	"US, 2015"	Chinese hamster ovary (CHO) cells	
P00533	Necitumumab	Portrazza	EGFR	Full-length antibody	Monospecific	Human	hIgG1	kappa	Unconjugated				None	-	Oncology	Non-small cell lung cancer	2015	2015	"US, 2015"	Murine myeloma non-secreting 0 (NS0) cells	
x	Dinutuximab	Unituxin	GD2	Full-length antibody	Monospecific	Chimeric mouse/human	hIgG1	kappa	Unconjugated				None	-	Oncology	Neuroblastoma	2017; 2015#	2015	"US, 2015"	Murine myeloma cells (Sp2/0)	
Q16552	Secukinumab	Cosentyx	IL-17a	Full-length antibody	Monospecific	Human	hIgG1	kappa	Unconjugated				None	-	Immunology	Psoriasis	2015	2015	"Japan, 2014"	Chinese hamster ovary (CHO) cells	
P05113	Mepolizumab	Nucala	IL-5	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				None	-	Immunology	Severe eosinophilic asthma	2015	2015	"US, 2015"	Chinese hamster ovary (CHO) cells	
Q8NBP7	Alirocumab	Praluent	PCSK9	Full-length antibody	Monospecific	Human	hIgG1	kappa	Unconjugated				None	-	Other	High cholesterol	2015	2015	"US, 2015"	Chinese hamster ovary (CHO) cells	
P28907	Daratumumab	Darzalex	CD38	Full-length antibody	Monospecific	Human	hIgG1	kappa	Unconjugated				None	-	Oncology	Multiple myeloma	2016	2015	"US, 2015"	Chinese hamster ovary (CHO) cells	
Q9NQ25	Elotuzumab	Empliciti	SLAMF7	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				None	-	Oncology	Multiple myeloma	2016	2015	"US, 2015"	Murine myeloma non-secreting 0 (NS0) cells	
Q16552	Ixekizumab	Taltz	IL-17a	Full-length antibody	Monospecific	Humanized	hIgG4	kappa	Unconjugated				S228P	Hinge stabilising	Immunology	Psoriasis	2016	2016	"US, 2016"	Chinese hamster ovary (CHO) cells	
P05113	Reslizumab	"Cinqaero, Cinqair"	IL-5	Full-length antibody	Monospecific	Humanized	hIgG4	kappa	Unconjugated				None	-	Immunology	Asthma	2016	2016	"US, 2016"	Murine myeloma non-secreting 0 (NS0) cells	
P16234	Olaratumab	Lartruvo	PDGFR_	Full-length antibody	Monospecific	Human	hIgG1	kappa	Unconjugated				None	-	Oncology	Soft tissue sarcoma	2016#	2016	"US, 2016"	Murine myeloma non-secreting 0 (NS0) cells	
P18177	Bezlotoxumab	Zinplava	Clostridium difficile enterotoxin B	Full-length antibody	Monospecific	Human	hIgG1	kappa	Unconjugated				None	-	Infectious Diseases	Prevention of Clostridium difficile infection recurrence	2017	2016	"US, 2016"	Chinese hamster ovary (CHO) cells	
Q9NZQ7	Atezolizumab	Tecentriq	PD-L1	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				Aglycosylated (N297A)	Remove Fc effector functions	Oncology	Bladder cancer	2017	2016	"US, 2016"	Chinese hamster ovary (CHO) cells	
P13423	Obiltoxaximab	Anthim	B. anthrasis PA	Full-length antibody	Monospecific	Chimeric mouse/human	hIgG1	kappa	Unconjugated				None	-	Infectious Diseases	Prevention of inhalational anthrax	2020	2016	"US, 2016"	Murine GS-NS0 myeloma cells	
Q96F46	Brodalumab	"Siliq, LUMICEF, Kyntheum"	IL-17R	Full-length antibody	Monospecific	Human	hIgG2	kappa	Unconjugated				None	-	Immunology	Plaque psoriasis	2017	2017	"Japan, 2016"	Chinese hamster ovary (CHO) cells	
P24394	Dupilumab	Dupixent	IL-4R _	Full-length antibody	Monospecific	Human	hIgG4	kappa	Unconjugated				S228P	Hinge stabilising	Immunology	Atopic dermatitis	2017	2017	"US, 2017"	Chinese hamster ovary (CHO) cells	
P20273	Inotuzumab ozogamicin	BESPONSA	CD22	Full-length antibody	Monospecific	Humanized	hIgG4	kappa	ADC	Acid-labile hydrozone linker	Calicheamicin	DNA-binding and double breaks induction	S228P	Hinge stabilising	Oncology	Acute lymphoblastic leukemia	2017	2017	"US, 2017"	Chinese hamster ovary (CHO) cells	
Q9NPF7	Guselkumab	TREMFYA	IL-23 p19	Full-length antibody	Monospecific	Human	hIgG1	lambda	Unconjugated				None	-	Immunology	Plaque psoriasis	2017	2017	"US, 2017"	Chinese hamster ovary (CHO) cells	
P08887	Sarilumab	Kevzara	IL-6R	Full-length antibody	Monospecific	Human	hIgG1	kappa	Unconjugated				None	-	Immunology	Rheumatoid arthritis	2017	2017	"Canada, 2017"	Chinese hamster ovary (CHO) cells	
Q9NZQ7	Avelumab	Bavencio	PD-L1	Full-length antibody	Monospecific	Human	hIgG1	lambda	Unconjugated				None	-	Oncology	Merkel cell carcinoma	2017	2017	"US, 2017"	Chinese hamster ovary (CHO) cells	
"P00742, P00740"	Emicizumab	Hemlibra	"Factor Ixa, X"	Full-length antibody	Bispecific	Humanized	hIgG4	kappa	Unconjugated				S228P; K196Q; F296Y; E356K; K439E; L445P; G446 > del; K447 > del	"Hinge stabilising, asymmetric electrostatic steering mutations for bispecific creation"	Hematological Disorders	Hemophilia A	2018	2017	"US, 2017"	Chinese hamster ovary (CHO) cells	
P11836	Ocrelizumab	OCREVUS	CD20	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				None	-	Immunology	Multiple sclerosis	2018	2017	"US, 2017"	Chinese hamster ovary (CHO) cells	
Q01344	Benralizumab	Fasenra	IL-5R _	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				Afucosylated	Improve Fc_RIIIa binding/Improve ADCC	Immunology	Asthma	2018	2017	"US, 2017"	"Chinese hamster ovary (CHO) cells, FUT8_/_ CHO cells (Potelligent® Technology)"	
Q9NZQ7	Durvalumab	IMFINZI	PD-L1	Full-length antibody	Monospecific	Human	hIgG1	kappa	Unconjugated				L234F; L235E; P331S	Remove Fc effector functions	Oncology	Bladder cancer	2018	2017	"US, 2017"	Chinese hamster ovary (CHO) cells	
P20138	Gemtuzumab ozogamicin	Mylotarg	CD33	Full-length antibody	Monospecific	Humanized	hIgG4	kappa	ADC	Acid-labile hydrozone linker	Calicheamicin	DNA-binding and double breaks induction	S228P	Hinge stabilising	Oncology	Acute myeloid leukemia	2018	2017; 2000#	"US, 2000"	Murine myeloma non-secreting 0 (NS0) cells	
Q16602	Erenumab (erenumab-aooe)	Aimovig	CGRP receptor	Full-length antibody	Monospecific	Human	hIgG2	lambda	Unconjugated				None	-	Neurological disorders	Migraine prevention	2018	2018	"US, 2018"	Chinese hamster ovary (CHO) cells	
P06881	Galcanezumab (galcanezumab-gnlm)	Emgality	CGRP	Full-length antibody	Monospecific	Humanized	hIgG4	kappa	Unconjugated				S228P; F234A; L235A	Remove Fc effector functions	Neurological disorders	Migraine prevention	2018	2018	"US, 2018"	Chinese hamster ovary (CHO) cells	
Q9GZV9	Burosumab (burosumab-twza)	Crysvita	FGF23	Full-length antibody	Monospecific	Human	hIgG1	kappa	Unconjugated				None	-	Genetic Diseases	X-linked hypophosphatemia	2018	2018	"EU, 2018"	Chinese hamster ovary (CHO) cells	
P03952	Lanadelumab (lanadelumab-flyo)	Takhzyro	Plasma kallikrelin	Full-length antibody	Monospecific	Human	hIgG1	kappa	Unconjugated				None	-	Genetic Diseases	Hereditary angioedema attacks	2018	2018	"US, 2018"	Chinese hamster ovary (CHO) cells	
P51679	Mogamulizumab (mogamulizumab-kpkc)	Poteligeo	CCR4	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				Afucosylated	Improve Fc_RIIIa binding/Improve ADCC	Oncology	Mycosis fungoides or Sézary syndrome	2018	2018	"Japan, 2012"	"Chinese hamster ovary (CHO) cells, FUT8_/_ CHO cells (Potelligent® Technology)"	
Q9NPF7	Tildrakizumab (tildrakizumab-asmn)	Ilumya	IL-23 p19	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				None	-	Immunology	Plaque psoriasis	2018	2018	"US, 2018"	Chinese hamster ovary (CHO) cells	
P06881	Fremanezumab (fremanezumab-vfrm)	Ajovy	CGRP	Full-length antibody	Monospecific	Humanized	hIgG2_a	kappa	Unconjugated				A330S; P331S	Remove Fc effector functions	Neurological disorders	Migraine prevention	2019	2018	"US, 2018"	Chinese hamster ovary (CHO) cells	
P01031	Ravulizumab (ravulizumab-cwvz)	Ultomiris	C5	Full-length antibody	Monospecific	Humanized	hIgG2(CH1-hinge)/hIgG4(CH2-CH3)	kappa	Unconjugated				M428L; N434S	Increase half-life	Hematological Disorders	Paroxysmal nocturnal hemoglobinuria	2019	2018	"US, 2018"	Chinese hamster ovary (CHO) cells	
Q15116	Cemiplimab (cemiplimab-rwlc)	Libtayo	PD-1	Full-length antibody	Monospecific	Human	hIgG4	kappa	Unconjugated				S228P	Hinge stabilising	Oncology	Cutaneous squamous cell carcinoma	2019	2018	"US, 2018"	Chinese hamster ovary (CHO) cells	
P01730	Ibalizumab (ibalizumab-uiyk)	Trogarzo	CD4	Full-length antibody	Monospecific	Humanized	hIgG4	kappa	Unconjugated				None	-	Infectious Diseases	HIV infection	2019	2018	"US, 2018"	Murine myeloma non-secreting 0 (NS0) cells	
P01579	Emapalumab (emapalumab-lzsg)	Gamifant	IFNg	Full-length antibody	Monospecific	Human	hIgG1	lambda	Unconjugated				None	-	Oncology	Primary hemophagocytic lymphohistiocytosis	NA	2018	"US, 2018"	Chinese hamster ovary (CHO) cells	
P20273	Moxetumomab pasudotox (moxetumomab pasudotox-tdfk)	Lumoxiti	CD22	dsFv immunotoxin	Monospecific	Murine	mIgG1 dsFv fused with PE38 exotoxin		Immunotoxin		PE38		Not applicable	-	Oncology	Hairy cell leukemia	2021	2018	"US, 2018"	E. coli bacteria	
P04275	Caplacizumab (caplacizumab-yhdp)	Cablivi	von Willebrand factor	Nanobody	Monospecific	Humanized	bivalent Nanobody	NA	Unconjugated				Not applicable	-	Immunology	Acquired thrombotic thrombocytopenic purpura	2018	2019	"EU, 2018"	E. coli bacteria	
Q9NPF7	Risankizumab (risankizumab-rzaa)	Skyrizi	IL-23 p19	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				L234A; L235A	Remove Fc effector functions	Immunology	Plaque psoriasis	2019	2019	"Japan, 2019"	Chinese hamster ovary (CHO) cells	
P40259	Polatuzumab vedotin (polatuzumab vedotin-piiq)	Polivy	CD79b	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	ADC	Protease-cleavable Valine-Citrulline (mc-val-cit PABC linker	Monomethyl Auristatin E (MMAE)	tubulin polimerization inhibitor	None	-	Oncology	Diffuse large B-cell lymphoma	2020	2019	"US, 2019"	Chinese hamster ovary (CHO) cells	
Q9BQB4	Romosozumab (romosozumab-aqqg)	Evenity	Sclerostin	Full-length antibody	Monospecific	Humanized	hIgG2	kappa	Unconjugated				None	-	Musculoskeletal Disorders	Osteoporosis in postmenopausal women at increased risk of fracture	2019	2019	"Japan, 2019"	Chinese hamster ovary (CHO) cells	
P15692	Brolucizumab (brolucizumab-dbll)	Beovu	VEGF-A	scFv	Monospecific	Humanized	hscFv	kappa	Unconjugated				Not applicable	-	Ophthalmology	Neovascular age-related macular degeneration	2020	2019	"US, 2019"	E. coli BL21(DE3) bacteria	
P16109	Crizanlizumab (crizanlizumab-tmca)	Adakveo	CD62 (aka P-selectin)	Full-length antibody	Monospecific	Humanized	hIgG2	kappa	Unconjugated				None	-	Hematological Disorders	Sickle cell disease	2020	2019	"US, 2019"	Chinese hamster ovary (CHO) cells	
Q96NY8	Enfortumab vedotin (enfortumab vedotin-ejfv)	Padcev	Nectin-4	Full-length antibody	Monospecific	Human	hIgG1	kappa	ADC	Protease-cleavable Valine-Citrulline (mc-val-cit PABC linker	Monomethyl Auristatin E (MMAE)	tubulin polymerization inhibitor	None	-	Oncology	Urothelial cancer	2022	2019	"US, 2019"	Chinese hamster ovary (CHO) cells	
P04626	"[fam-]trastuzumab deruxtecan, (fam-trastuzumab deruxtecan-nxki)"	Enhertu	HER2	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	ADC	Glycine-Glycine-Phenylalanine-Glycine (GGFG; Cleavable linker)	DXd	topoisomerase I inhibitor	None	-	Oncology	HER2+ metastatic breast cancer	2021	2019	"US, 2019"	Chinese hamster ovary (CHO) cells	
P08069	Teprotumumab (teprotumumab-trbw)	Tepezza	IGF-1R	Full-length antibody	Monospecific	Human	hIgG1	kappa	Unconjugated				None	-	Ophthalmology	Thyroid eye disease	NA	2020	"US, 2020"	Chinese hamster ovary (CHO) cells	
P06881	Eptinezumab (eptinezumab-jjmr)	VYEPTI	CGRP	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				Aglycosylated (N297A)	Remove Fc effector functions	Neurological disorders	Migraine prevention	2022	2020	"US, 2020"	Pichia pastoris yeast cells	
P28907	Isatuximab (isatuximab-irfc)	Sarclisa	CD38	Full-length antibody	Monospecific	Chimeric mouse/human	hIgG1	kappa	Unconjugated				None	-	Oncology	Multiple myeloma	2020	2020	"US, 2020"	Chinese hamster ovary (CHO) cells	
P09758	Sacituzumab govitecan (sacituzumab govitecan-hziy)	TRODELVY	TROP-2	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	ADC	pH-sensitive cleavable linker	SN38	topoisomerase I inhibitor	None	-	Oncology	Triple-neg. breast cancer	2021	2020	"US, 2020"	Murine myeloma cells	
P15391	Inebilizumab (inebilizumab-cdon)	Uplizna	CD19	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				Afucosylated	Improve Fc_RIIIa binding/Improve ADCC	Immunology	Neuromyelitis optica spectrum disorders	2022	2020	"US, 2020"	"Chinese hamster ovary (CHO) cells, FUT8_/_ CHO cells (Potelligent® Technology)"	
P15391	Tafasitamab (tafasitamab-cxix)	"Monjuvi, Minjuvi"	CD19	Full-length antibody	Monospecific	Humanized	hIgG1/2 hybrid	kappa	Unconjugated				S239D; I332E	Improve Fc_RIIIa binding/Improve ADCC	Oncology	Diffuse large B-cell lymphoma	2021	2020	"US, 2020"	Chinese hamster ovary (CHO) cells	
Q02223	Belantamab mafodotin (belantamab mafodotin-blmf)	BLENREP	B-cell maturation antigen	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	ADC	noncleavable maleimidocaproyl (mc) linker	Monomethyl Auristatin F (MMAF)	tubulin polymerization inhibitor	Afucosylated	Improve Fc_RIIIa binding/Improve ADCC	Oncology	Multiple myeloma	2020	2020	"US, 2020"	"Chinese hamster ovary (CHO) cells, FUT8_/_ CHO cells (Potelligent® Technology)"	
P08887	Satralizumab (satralizumab-mwge)	Enspryng	IL-6R	Full-length antibody	Monospecific	Humanized	hIgG2	kappa	Unconjugated				None	-	Immunology	Neuromyelitis optica spectrum disorder	2021	2020	"Canada, 2020"	Chinese hamster ovary (CHO) cells	
Q05320	"Atoltivimab, maftivimab, and odesivimab-ebgn"	Inmazeb	Ebola virus	"Full-length antibodies, mixture of 3"	Monospecific	Human	hIgG1	kappa	Unconjugated				None	-	Infectious Diseases	Ebola virus infection	NA	2020	"US, 2020"	Chinese hamster ovary (CHO) cells	
x	Naxitamab-gqgk	DANYELZA	GD2	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				None	-	Oncology	High-risk neuroblastoma and refractory osteomedullary disease	NA	2020	"US, 2020"	Chinese hamster ovary (CHO) cells	
P04626	Margetuximab-cmkb	MARGENZA	HER2	Full-length antibody	Monospecific	Chimeric mouse/human	hIgG1	kappa	Unconjugated				F243L; R292P; Y300L; V305I; P396L	Improve Fc_RIIIa binding/Improve ADCC and decrease affinity for human inhibitory Fc_RIIB (CD32B)	Oncology	HER2+ metastatic breast cancer	NA	2020	"US, 2020"	Chinese hamster ovary (CHO) cells	
Q05320	Ansuvimab-zykl	Ebanga	Ebola virus glycoprotein	Full-length antibody	Monospecific	Human	hIgG1	kappa	Unconjugated				None	-	Infectious Diseases	Ebola virus infection	NA	2020	"US, 2020"	Chinese hamster ovary (CHO) cells	
Q9Y5C1	Evinacumab	Evkeeza	Angiopoietin-like 3	Full-length antibody	Monospecific	Human	hIgG4	kappa	Unconjugated				S228P	Hinge stabilising	Genetic Diseases	Homozygous familial hypercholesterolemia	2021	2021	"US, 2021"	Chinese hamster ovary (CHO) cells	
P15391	Loncastuximab tesirine	Zynlonta	CD19	Full-length antibody	Monospecific	Humanized	hIgG1/k	kappa	ADC	Protease-cleavable Valine-Citrulline linker	pyrrolobenzodiazepines (PBD) dimer SG3199	DNA minor-groove binding	None	-	Oncology	Diffuse large B-cell lymphoma	EU review	2021	"US, 2021"	Chinese hamster ovary (CHO) cells	
Q15116	Dostarlimab	Jemerli	PD-1	Full-length antibody	Monospecific	Humanized	hIgG4	kappa	Unconjugated				S228P	Hinge stabilising	Oncology	Endometrial cancer	2021	2021	"EU, 2021"	Chinese hamster ovary (CHO) cells	
"P00533, P08581"	Amivantamab	RYBREVANT	"EGFR, cMET"	Full-length antibody	Bispecific	Human	hIgG1		Unconjugated				Low-fucose; K409R; F405L	Improve Fc_RIIIa binding/Improve ADCC; Controlled Fab arm exchange for bispecific generation	Oncology	NSCLC w/ EGFR exon 20 insertion mutations	2021	2021	"US, 2021"	"Chinese hamster ovary (CHO) cells, Low-fucose production cells"	
P05067	Aducanumab	ADUHELM	Amyloid beta	Full-length antibody	Monospecific	Human	hIgG1	kappa	Unconjugated				None	-	Neurological disorders	Alzheimer's disease	MAA withdrawn	2021	"US, 2021"	Chinese hamster ovary (CHO) cells	
P35225	Tralokinumab	Adtralza	IL-13	Full-length antibody	Monospecific	Human	hIgG4	lambda	Unconjugated				None	-	Immunology	Atopic dermatitis	2021	2021	"EU, 2021"	Mouse myeloma cells	
P07766	Teplizumab	(Pending)	CD3	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				L234A; L235A	Remove Fc effector functions	Immunology	Type 1 diabetes	NA	In review (2nd cycle)		To be confirmed	
O00187	Narsoplimab	(Pending)	MASP-2	Full-length antibody	Monospecific	Human	hIgG4	lambda	Unconjugated				S228P	Hinge stabilising	Hematological Disorders	Hematopoietic stem cell transplant-associated thrombotic microangiopathies	NA	In review		To be confirmed	
Q15116	Retifanlimab	(Pending)	PD-1	Full-length antibody	Monospecific	Humanized	hIgG4	kappa	Unconjugated				S228P	Hinge stabilising	Oncology	Carcinoma of the anal canal	MAA withdrawn	In review (2nd cycle)		To be confirmed	
P16422	Oportuzumab monatox	(Pending)	EpCAM	scFv immunotoxin	Monospecific	Humanized	hscFv fused with PE38 exotoxin	To be confirmed	Immunotoxin		PE38		Not applicable	-	Oncology	Bladder cancer	NA	In review (2nd cycle)		To be confirmed	
P17181	"Anifrolumab, anifrolumab-fnia"	Saphnelo	IFNAR1	Full-length antibody	Monospecific	Human	hIgG1	kappa	Unconjugated				L234F; L235E; P331S	Remove Fc effector functions	Immunology	Systemic lupus erythematosus	2022	2021	"US, 2021"	Mouse myeloma cells (NS0)	
P01589	Inolimomb	(Pending)	CD25	Full-length antibody	Monospecific	Murine	mIgG1	kappa	Unconjugated				None	-	Immunology	Graft vs. host disease	NA	In review		To be confirmed	
"Q16552, Q96PD4"	Bimekizumab	Bimzelx	IL-17A and IL-17F (overlapping binding site)	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				None	-	Immunology	Psoriasis	2021	In review	"EU, 2021"	Chinese hamster ovary (CHO) cells	
P09871	"Sutimlimab, sutimlimab-jome"	Enjaymo	C1s	Full-length antibody	Monospecific	Humanized	hIgG4	kappa	Unconjugated				S228P; L235E	Hinge stabilising; remove Fc effector functions	Immunology	Cold agglutinin disease	EU review	2022	"US, 2022"	Chinese hamster ovary (CHO) cells	
P11836	Ublituximab	(Pending)	CD20	Full-length antibody	Monospecific	Chimeric	hIgG1	kappa	Unconjugated				Low fucose	Improve Fc_RIIIa binding/Improve ADCC	Immunology	Multiple sclerosis	EU review	In review		YB2/0 cells	
P13726	"Tisotumab vedotin, tisotumab vedotin-tftv"	TIVDAK	Tissue factor	Full-length antibody	Monospecific	Human	hIgG1	kappa	ADC	Cleavable mc-val-cit-PABC type linker	Monomethyl Auristatin E (MMAE)	tubulin polymerization inhibitor	None	-	Oncology	Cervical cancer	NA	2021	"US, 2021"	Chinese hamster ovary (CHO) cells	
Q15116	Toripalimab	Tuoyi	PD-1	Full-length antibody	Monospecific	Humanized	hIgG4	kappa	Unconjugated				S228P	Hinge stabilising	Oncology	Nasopharyngeal carcinoma	NA	In review		To be confirmed	
Q15116	Sintilimab	Tyvyt	PD-1	Full-length antibody	Monospecific	Human	hIgG4	kappa	Unconjugated				S228P	Hinge stabilising	Oncology	Non-small cell lung cancer	NA	In review		To be confirmed	
Q969D9	Tezepelumab	Tezspire	Thymic stromal lymphopoietin	Full-length antibody	Monospecific	Human	hIgG2	lambda	Unconjugated				None	-	Immunology	Severe asthma	EU review	2021	"US, 2021"	Chinese hamster ovary (CHO) cells	
Q5ZPR3	Omburtamab	(Pending)	B7-H3 (CD276)	Full-length antibody	Monospecific	Murine	hIgG1	kappa	Radiolabeled		Iodine-131	I-131 produces beta and gamma emissions	None	-	Oncology	Central nervous system/leptomeningeal metastasis from neuroblastoma	EU review	In review		To be confirmed	
Q15116	Penpulimab	(Pending)	PD-1	Full-length antibody	Monospecific	Humanized	hIgG1	To be confirmed	Unconjugated				L234A L235A G237A	Reduce Fc effector functions	Oncology	Metastatic nasopharyngeal carcinoma	NA	In review		To be confirmed	
P15692	"Faricimab, faricimab-svoa"	Vabysmo	"VEGF-A, Ang-2"	Full-length antibody	Bispecific	Humanized/human	hIgG1	kappa/lambda	Unconjugated				L234A; L235A; P329G; I253A; H310A; H435A; S354C + T366W (in heavy chain A); Y349C + T366S + L368A + Y407V (in heavy chain B)	"Remove Fc effector functions; Reduce half-life; CrossMab ""knob-in-hole"" mutations for bispecific generation"	Ophthalmology	"Neovascular age-related macular degeneration, diabetic macular edema"	EU review	2022	"US, 2022"	Chinese hamster ovary (CHO) cells	
"P40967, P07766"	Tebentafusp	KIMMTRAK	"gp100, CD3"	TCR-scFv fusion protein	Bispecific	Humanized	hscFV fused with a TCR	To be confirmed	Fusion protein				None	-	Oncology	Metastatic uveal melanoma	2022	2022	"US, 2022"	E. coli bacteria	
Q15116	Tislelizumab	(Pending)	PD-1	Full-length antibody	Monospecific	Humanized	hIgG4	kappa	Unconjugated				"S228P; E233P, F234V, L235A, D265A"	Hinge stabilising; Abrogate Fc_Rs binding	Oncology	Esophageal squamous cell carcinoma	EU review	In review		To be confirmed	
P18627	Relatlimab	Opdualag	LAG-3	Full-length antibody	Monospecific	Human	hIgG4	kappa	Unconjugated				S228P	Hinge stabilising	Oncology	Melanoma	EU review	2022	"US, 2022"	Chinese hamster ovary (CHO) cells	
x	Lecanemab	(Pending)	Amyloid beta protofibrils	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				None	-	Neurological disorders	Alzheimer's disease	NA	In review		To be confirmed	
P0DTC2	Casirivimab + imdevimab	"REGEN-COV, Ronapreve"	SARS-CoV-2	"Full-length antibodies, mixture of 2"	Monospecific	Human	hIgG1	kappa and lambda	Unconjugated				None	-	Infectious diseases	COVID-19	2021	In review	"Japan, 2021"	Chinese hamster ovary (CHO) cells	
P0DTC2	Regdanvimab	Regkirona	SARS-CoV-2	Full-length antibody	Monospecific	Human	hIgG1	lambda	Unconjugated				None	-	Infectious diseases	COVID-19	2021	NA	"Republic of Korea, 2021"	Chinese hamster ovary (CHO)-K1 cells	
Q9HB29	Spesolimab	(Pending)	IL-36 receptor	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				L234A/L235A	Remove Fc effector functions	Immunology	Generalized pustular psoriasis	EU review	In review		To be confirmed	
P05067	Donanemab	(Pending)	"Amyloid beta, N3pG (N-terminal truncated)"	Full-length antibody	Monospecific	Humanized	hIgG1	kappa	Unconjugated				None	-	Neurological disorders	Alzheimer's disease	NA	In review		To be confirmed	
P0DTC2	Sotrovimab	Xevudy	SARS-CoV-2	Full-length antibody	Monospecific	Human	hIgG1	kappa	Unconjugated				M428L /N434S	Extends half-life	Infectious diseases	COVID-19	2021	NA	"Australia, 2021"	Chinese hamster ovary (CHO) cells	
"Q02223, P07766"	Teclistamab	(Pending)	"BCMA, CD3"	Full-length antibody	Bispecific	Humanized	"IgG4; Hetero H, HL exchanged"	lambda	Unconjugated				"Hetero HH: F405L-R409K x WT (R409); both chains: S228P and F234A, L235A"	"Hinge-stabilising (S228P) and Fc-silencing (F234A, L235A)"	Oncology	Multiple myeloma	EU review	In review		To be confirmed	
"P11836, P07766"	Mosunetuzumab	Lunsumio	"CD20, CD3"	Full-length antibody	Bispecific	Humanized	"IgG1; Hetero H, HL assembly"	kappa	Unconjugated				Hetero HH: T366W x T366S-L368A-Y407V (KiH); N297G (Fc-aglycosylated)	Improve Fc_RIIIa binding/Improve ADCC	Oncology	Follicular lymphoma	2022	In review	"EU, 2022"	Chinese hamster ovary (CHO) cells	
P16410	Tremelimumab	(Pending)	CTLA-4	Full-length antibody	Monospecific	Human	IgG2	kappa	Unconjugated				None	-	Oncology	Antineoplastic; liver cancer	EU review	In review		To be confirmed	
P03420	Nirsevimab	(Pending)	RSV	Full-length antibody	Monospecific	Human	IgG1	kappa	Unconjugated				"M252Y, S254T, T256E"	Extends half-life	Infectious diseases	Respiratory syncytial virus infection	EU review	NA		To be confirmed	
P0DTC2	"Tixagevimab, cilgavimab"	Evusheld	SARS-CoV-2	"Full-length antibodies, mixture of 2"	Monospecific	Human	IgG1	kappa	Unconjugated				L234F L235E M252Y S254T T256E P331S	Reduce Fc effector function (L234F L235E P331S) and extend half-life ( M252Y S254T T256E)	Infectious diseases	COVID-19	2022	EUA granted	"EU, 2022"	Chinese hamster ovary (CHO) cells	
P15328	Mirvetuximab soravtansine	(Pending)	Folate receptor alpha	Full-length antibody	Monospecific	Humanized	IgG1	kappa	ADC	cleavable sulfo-SPDB linker	DM4	Tubulin polymerization inhibitor	None	-	Oncology	Ovarian cancer	NA	In review		To be confirmed	
P00533	Nimotuzumab	"TheraCIM, BIOMAB-EGFR"	EGFR	Full-length antibody	Monospecific	Humanized	IgG1	kappa	Unconjugated				None	-	Oncology	Head and neck cancer	NA	NA	"Cuba, 2002"	To be confirmed	
P30203	Itolizumab	Alzumab	CD6	Full-length antibody	Monospecific	Humanized	IgG1	kappa	Unconjugated				None	-	Immunology	Psoriasis	NA	NA	"India, 2013"	To be confirmed	
P16288		RabiShield	Rabies virus G glycoprotein	Full-length antibody	Monospecific	Human	IgG1		Unconjugated						Infectious disease	Rabies exposure	NA	NA	"India, 2016"	To be confirmed	
P16288	Docaravimab and Miromavimab	Twinrab	Rabies virus	Full-length antibody	Two monospecific antibodies	Murine	IgG2b and IgG1	kappa	Unconjugated				None	-	Infectious disease	Rabies exposure	NA	NA	"India, 2019"	To be confirmed	
Q15116	Camrelizumab	AiRuiKa	PD-1	Full-length antibody	Monospecific	Humanized	IgG4	kappa	Unconjugated				S228P	Hinge stabilisation	Oncology	Hodgkin's lymphoma	NA	NA	"China, 2019"	To be confirmed	
P04626	Inetetamab	Cipterbin	HER2	Full-length antibody	Monospecific	Humanized	IgG1		Unconjugated					Enhanced ADCC/ADCP (exact mutations not found)	Oncology	HER2-positive metastatic breast cancer	NA	NA	"China, 2020"	To be confirmed	
P04626	Disitamab vedotin	Aidixi	HER2	Full-length antibody	Monospecific	Humanized	IgG1	kappa	ADC	cleavable maleimidocaproyl-valyl-citrullinyl-p-amiobenzyloxycarbonyl (mc-val-cit-PABC) type linker	MMAE		None	-	Oncology	Gastric cancer	NA	NA	"China, 2021"	To be confirmed	
Q9NZQ7	Envafolimab	ENWEIDA	PD-L1	Single domain antibody-Fc	Monospecific	Humanized single doman; human Fc	IgG1		Unconjugated				C220S/D265A/P331S	Reduce Fc effector function (ADCC/ADCP)	Oncology	Microsatellite instability-high or deficient MisMatch Repair advanced solid tumors	NA	NA	"China, 2021"	To be confirmed	
Q9NZQ7	Sugemalimab	Cejemly®	PD-L1	Full-length antibody	Monospecific	Human	IgG4	lambda	Unconjugated				S228P	Hinge stabilisation	Oncology	Non-small cell lung cancer	NA	NA	"China, 2021"	To be confirmed	
Q15116	Zimberelimab		PD-1	Full-length antibody	Monospecific	Human	IgG4	lambda	Unconjugated				S228P	Hinge stabilisation	Oncology	Classical Hodgkin’s lymphoma	NA	NA	"China, 2021"	To be confirmed	
P0DTC2	Amubarvimab + Romlusevimab		SARS-CoV-2	Full-length antibody	Two monospecific antibodies	Human	IgG1	kappa and lambda2	Unconjugated				M252Y/S254T/T256E	Half-life extension	Infectious disease	SARS-CoV-2 infection	NA	NA	"China, 2021"	To be confirmed	
P00533	Cetuximab saratolacan	Akalux® IV Infusion	EGFR	Full-length antibody	Monospecific	Chimeric	IgG1	kappa	Photoimmunotherapy		IRDye® 700DX		None	-	Oncology	Head and neck cancer	NA	NA	"Japan, 2020"	To be confirmed	
P02786	Pabinafusp alfa	IZCARGO	Transferrin receptor	Full-length antibody	Monospecific	Humanized	IgG1	kappa	Immunoconjugate		Iduronate-2-sulfatase		None	-	Metabolic disorders	Mucopolysaccharidosis type II	NA	NA	"Japan, 2021"	To be confirmed	
Q16552	Netakimab	Efleira	IL-17	Full-length antibody	Monospecific	Humanized	IgG1	kappa	Unconjugated				M252Y/S254T/T256E	Half-life extension	Immunology	Plaque psoriasis	NA	NA	"Russia, 2019"	To be confirmed	
P08887	Levilimab	Ilsira	IL-6 receptor	Full-length antibody	Monospecific	Human	IgG1	kappa	Unconjugated				E233P/L234V/L235A and M252Y/S254T/T256E	Reduce Fc effector function and extend half-life	Immunology	Inflammation due to COVID-19 infection	NA	NA	"Russia, 2020"	To be confirmed	
P05231	Olokizumab	ARTLEGIA	IL-6	Full-length antibody	Monospecific	Humanized	IgG4	kappa	Unconjugated				S228P	Hinge stabilisation	Immunology	Rheumatoid arthritis	NA	NA	"Russia, 2020"	To be confirmed	
Q15116	Prolgolimab	Forteca	PD-1	Full-length antibody	Monospecific	Human	IgG1	V-lambda C-kappa	Unconjugated				L234A/L235A	Reduce Fc effector function	Oncology	Melanoma	NA	NA	"Russia, 2020"	To be confirmed	
"Q15116, P16410"	Cadonilimab		"PD-1, CTLA4"	Full-length antibody	Bispecific	Humanized	IgG1	kappa	Unconjugated				L234A/L235A/G237A	Reduce Fc effector function	Oncology	Cervical cancer	NA	NA	"China, 2022"	To be confirmed	
Q15116	Geptanolimab (Genolimzumab)		PD-1	Full-length antibody	Monospecific	Humanized	IgG4	kappa	Unconjugated				S228P	Hinge stabilisation	Oncology	Peripheral T cell lymphoma	NA	NA	Regulatory review in China	To be confirmed	
P11836	Ripertamab		CD20	Full-length antibody	Monospecific	Chimeric	IgG1	kappa	Unconjugated				None	-	Oncology	Non-Hodgkin's lymphoma	NA	NA	Regulatory review in China	To be confirmed	
Q15116	Serplulimab		PD-1	Full-length antibody	Monospecific	Humanized	IgG4	kappa	Unconjugated				S228P	Hinge stabilisation	Oncology	Microsatellite instability-high solid tumors	NA	NA	"China, 2022"	To be confirmed	
Q9NZQ7	Socazolimab		PD-L1	Full-length antibody	Monospecific	Human	IgG1	lambda2	Unconjugated				None	-	Oncology	Cervical cancer	NA	NA	Regulatory review in China	To be confirmed	
"P01375, P02768"	Ozoralizumab		"TNF, albumin"	Nanobody	Bispecific	Humanized			Unconjugated				None	-	Immunology	Rheumatoid arthritis	NA	NA	Regulatory review in Japan	To be confirmed	
Q8NI17	Nemolizumab	Mitchga	IL-31 receptor alpha	Full-length antibody	Monospecific	Humanized	IgG2	kappa	Unconjugated				C222S and H268Q	"Structure stability, possibly reduce Fc effector function"	Immunology	Pruritus with atopic dermatitis	NA	NA	"Japan, 2022"	To be confirmed	
P03524	Ormutivimab		Rabies virus surface glycoprotein 4	Full-length antibody	Monospecific	Human	IgG1	lambda2	Unconjugated				None	-	Infectious disease	Post-exposure prophylaxis of rabies	NA	NA	"China, 2022"	Chinese hamster ovary (CHO)-K1 cell s	
"P07766, P11836"	Glofitamab		"CD20, CD3e"	CrossMab; Fab-Fc(G1) x Fab-Fab-Fc	Bispecific		IgG1	lambda/kappa	Unconjugated				"Hetero HH: S354C-T366W x Y349C-T366S-L368A-Y407V (KiH and extra cysteines); HL-pairing: CrossMab; both chains: L234A, L235A, P329G (Fc-silencing)"	"Chain pairing, Fc silencing"	Oncology	Diffuse large B-cell lymphoma	EU review	NA	NA	To be confirmed	
Q9NPF7	Mirikizumab	(Pending)	IL-23p19	Full-length antibody	Monospecific	Humanized	IgG4	kappa	Unconjugated				"S228P; F234A, L235A"	Hinge stabilisation; Reduce Fc effector function	Immunology	Ulcerative colitis	EU review	In review		To be confirmed	
P04626	Trastuzumab duocarmazine	(Pending)	HER2	Full-length antibody	Monospecific	Humanized	IgG1	kappa	ADC	cleavable linker-drug (vc-seco-DUBA)	Duocarmycin	DNA minor-groove-binding alkylation	None		Cancer	Breast cancer	EU review	In review		To be confirmed	
Q15116	Pucotenlimab	Puyouheng	PD-1	Full-length antibody	Monospecific	Humanized	IgG4	kappa	Unconjugated				"S228P, S254T, V308P, N434A"	"Hinge stabilsation, half-life extension"	Cancer	"Metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) advanced solid tumors,"	NA	NA	"China, 2022"	To be confirmed	